Why the study?
Does the addition of discharge and change in NT-proBNP to known risk markers (ÉLAN-HF Score) improve the prediction of adverse events in patients hospitalised for ADHF?
Does the addition of discharge and change in NT-proBNP to known risk markers (ÉLAN-HF Score) improve the prediction of adverse events in patients hospitalised for ADHF?
The ÉLAN-HF Score, which incorporates discharge NT-proBNP and its change during hospitalization, improves the prediction of adverse events in patients with acute decompensated heart failure.
No takes yet. Share an insight, caveat, or question.
May enhance discharge risk stratification in ADHF; extends prior models but leaves open prospective validation before adoption.
Salah et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: